Vigabatrin-Associated Visual Field Defects

Abstract

The prevalence, risk factors, and long-term outcome of vigabatrin-associated visual field defects were examined in 60 adult patients with partial epilepsy treated with vigabatrin for 7 months to 14 years at the University of Kuopio Hospital, Finland.

Keywords

• kinetic goldmann perimetries
• visual field constriction
• bilateral concentric defects